Gen-Probe has hired Carl Hull as executive vice president and COO, the company said this week.
 
Hull recently was at Applied Biosystems, where he served as vice president and general manager of the company’s Sequence Detection System and Microarray business unit.
 
Hull also was a CEO at Applied Imaging and he worked in marketing and sales at Ventana Medical Systems and at Abbott Laboratories.
 

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.